Itau Unibanco Holding S.A. Arcturus Therapeutics Holdings Inc. Transaction History

Itau Unibanco Holding S.A.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$14.72 - $23.97 $117 - $191	-8 Reduced 0.71%	1,111 $26,000
Q4 2022 Feb 09, 2023	SELL	$14.14 - $23.06 $7,140 - $11,645	-505 Reduced 31.1%	1,119 $18,000
Q3 2022 Nov 14, 2022	SELL	$13.05 - $22.13 $9,448 - $16,022	-724 Reduced 30.83%	1,624 $24,000
Q2 2022 Aug 15, 2022	BUY	$12.26 - $31.17 $13,167 - $33,476	1,074 Added 84.3%	2,348 $37,000
Q4 2021 Feb 14, 2022	SELL	$34.2 - $47.56 $19,152 - $26,633	-560 Reduced 30.53%	1,274 $50,000
Q3 2021 Nov 12, 2021	BUY	$27.88 - $58.25 $17,536 - $36,639	629 Added 52.2%	1,834 $88,000
Q2 2021 Aug 17, 2021	BUY	$25.79 - $42.11 $31,076 - $50,742	1,205 New	1,205 $41,000

168

26M

163K

173K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $380M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.